| Name | Title | Contact Details |
|---|
Four years ago, we set out to create a product that automatically organizes your photos and memories. Along the way, we`ve secured 12 billion photos and videos for tens of millions of users in 95 countries. Today, we offer best-in-class face recognition technology with the most comprehensive, real-life dataset of any private company in the world. Our models have identified hundreds of millions of global clustered identities to date, all derived directly from mobile consumers.
Leader in Azure, GCP, AWS cloud certification & training courses. Hands-on experience. Business & Individual plans, with Free plans available. Start learning today.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
R O I Systems Inc is a Minneapolis, MN-based company in the Software and Internet sector.